https://www.selleckchem.com/pr....oducts/lipofermata.h
4%. Increasing ECN was associated equally with ≤1-year (HR 1.28 [95% CI 1.25-1.30]) and1-year (HR 1.19 [95% CI 1.17-1.20]) mortality. A predictive model including age, sex, BMI, PPM type, race, and ECN had greater discriminative ability (p.0001) than a bedside model (age, sex) for the primary outcome. Across the heterogeneity of indications for PPM placement, multimorbidity is increasingly common. The association of multimorbidity to mortality (≤1-year,1-year) should be routinely discussed during the shared decision-maki
Like
Comment
Share
